277 related articles for article (PubMed ID: 10986901)
1. [Treatment of hepatic encephalopathy with flumazenil].
Elkjaer JM; Jensen TU; Emborg J
Ugeskr Laeger; 2000 Aug; 162(35):4681-4. PubMed ID: 10986901
[TBL] [Abstract][Full Text] [Related]
2. Flumazenil for hepatic coma in patients with liver cirrhosis: an Italian multicentre double-blind, placebo-controlled, crossover study.
Barbaro G; Di Lorenzo G; Soldini M; Marziali M; Bellomo G; Belloni G; Grisorio B; Annese M; Bacca D; Barbarini G
Eur J Emerg Med; 1998 Jun; 5(2):213-8. PubMed ID: 9846248
[TBL] [Abstract][Full Text] [Related]
3. Benzodiazepine receptor antagonists for acute and chronic hepatic encephalopathy.
Als-Nielsen B; Kjaergard LL; Gluud C
Cochrane Database Syst Rev; 2001; (4):CD002798. PubMed ID: 11687160
[TBL] [Abstract][Full Text] [Related]
4. [Current possibilities in the therapy of hepatic encephalopathy].
Meier PJ; Bansky G
Schweiz Med Wochenschr; 1990 Apr; 120(15):553-6. PubMed ID: 2159659
[TBL] [Abstract][Full Text] [Related]
5. [Chronic hepatic encephalopathy treated by long-term intravenous administration of flumazenil in ambulatory care].
Péroux JL; Paolini O; Tran A; Frappa B; Rampal P
Gastroenterol Clin Biol; 1996 Feb; 20(1):106-8. PubMed ID: 8734316
[TBL] [Abstract][Full Text] [Related]
6. Flumazenil therapy for hepatic encephalopathy. A double-blind cross over study.
Van der Rijt CC; Schalm SW; Meulstee J; Stijnen T
Gastroenterol Clin Biol; 1995; 19(6-7):572-80. PubMed ID: 7590022
[TBL] [Abstract][Full Text] [Related]
7. Benzodiazepine receptor antagonists for hepatic encephalopathy.
Als-Nielsen B; Gluud LL; Gluud C
Cochrane Database Syst Rev; 2004; (2):CD002798. PubMed ID: 15106178
[TBL] [Abstract][Full Text] [Related]
8. Flumazenil for hepatic encephalopathy grade III and IVa in patients with cirrhosis: an Italian multicenter double-blind, placebo-controlled, cross-over study.
Barbaro G; Di Lorenzo G; Soldini M; Giancaspro G; Bellomo G; Belloni G; Grisorio B; Annese M; Bacca D; Francavilla R; Barbarini G
Hepatology; 1998 Aug; 28(2):374-8. PubMed ID: 9695999
[TBL] [Abstract][Full Text] [Related]
9. Hepatic encephalopathy: nomenclature, pathogenesis and treatment.
Quero Guillén JC; Carmona Soria I; García Montes JM; Jiménez Sáenz M; Herrerías Gutiérrez JM
Rev Esp Enferm Dig; 2003 Feb; 95(2):135-42, 127-34. PubMed ID: 12760720
[TBL] [Abstract][Full Text] [Related]
10. Treatment of hepatic encephalopathy (HE) with the benzodiazepine antagonist flumazenil: a pilot study.
Meier R; Gyr K
Eur J Anaesthesiol Suppl; 1988; 2():139-46. PubMed ID: 2842130
[TBL] [Abstract][Full Text] [Related]
11. Flumazenil in cirrhotic patients in hepatic coma: a randomized double-blind placebo-controlled crossover trial.
Pomier-Layrargues G; Giguère JF; Lavoie J; Perney P; Gagnon S; D'Amour M; Wells J; Butterworth RF
Hepatology; 1994 Jan; 19(1):32-7. PubMed ID: 8276366
[TBL] [Abstract][Full Text] [Related]
12. [Benzodiazepine antagonists in the treatment of heptic encephalopathy].
Ferenci P; Grimm G
Leber Magen Darm; 1989 Dec; 19(6):322-5. PubMed ID: 2575692
[TBL] [Abstract][Full Text] [Related]
13. Evoked potentials and the effect of flumazenil in patients with liver cirrhosis.
Ozyilkan E; Kahraman H; Onar M; Kesim G; Arik Z
East Afr Med J; 1997 Apr; 74(4):210-2. PubMed ID: 9299818
[TBL] [Abstract][Full Text] [Related]
14. [Evaluation of the therapeutic effect of flumazenil in hepatic encephalopathy using cerebral cartography].
Bello Mimbrera G; García de León M; de la Torre Gutiérrez S; Montero Vázquez J; Torres Salcines J; de la Torre Fernández JM
Rev Esp Enferm Apar Dig; 1989 Mar; 75(3):277-9. PubMed ID: 2499914
[TBL] [Abstract][Full Text] [Related]
15. [Flumazenil and hepatic failure].
Larsen FS
Ugeskr Laeger; 2000 Nov; 162(45):6107. PubMed ID: 11107959
[No Abstract] [Full Text] [Related]
16. An interaction between benzodiazepines and neuroactive steroids at GABA A receptors in cultured hippocampal neurons.
Ahboucha S; Coyne L; Hirakawa R; Butterworth RF; Halliwell RF
Neurochem Int; 2006 Jun; 48(8):703-7. PubMed ID: 16487630
[TBL] [Abstract][Full Text] [Related]
17. Flumazenil therapy for hepatic encephalopathy in cirrhotic patients: a double-blind pragmatic randomized, placebo study.
Cadranel JF; el Younsi M; Pidoux B; Zylberberg P; Benhamou Y; Valla D; Opolon P
Eur J Gastroenterol Hepatol; 1995 Apr; 7(4):325-9. PubMed ID: 7600138
[TBL] [Abstract][Full Text] [Related]
18. [The use of flumazenil in the treatment of hepatic encephalopathy secondary to acute liver failure. A report of 2 cases].
Díaz de León-Ponce M; Eid-Lidt G; Castañón-González JA; Deseaño-Estudillo JL; Reyes B
Gac Med Mex; 1993; 129(5):347-50. PubMed ID: 7926421
[No Abstract] [Full Text] [Related]
19. The efficacy of flumazenil in subclinical to mild hepatic encephalopathic ambulatory patients. A prospective, randomised, double-blind, placebo-controlled study.
Dursun M; Caliskan M; Canoruc F; Aluclu U; Canoruc N; Tuzcu A; Yilmaz S; Isikdogan A; Ertem M
Swiss Med Wkly; 2003 Feb; 133(7-8):118-23. PubMed ID: 12644958
[TBL] [Abstract][Full Text] [Related]
20. Is flumazenil an alternative for the treatment of hepatic encephalopathy?
Reyes D; Barrera F
Medwave; 2017 Dec; 17(9):e7113. PubMed ID: 29286356
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
